Cargando…
A Clinical Risk Assessment of a 3D-Printed Patient-Specific Scaffold by Failure Modes and Effects Analysis
This study aims to carry out a risk assessment to identify and rectify potential clinical risks of a 3D-printed patient-specific scaffold for large-volume alveolar bone regeneration. A survey was used to assess clinicians’ perceptions regarding the use of scaffolds in the treatment of alveolar defec...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369557/ https://www.ncbi.nlm.nih.gov/pubmed/35955377 http://dx.doi.org/10.3390/ma15155442 |
_version_ | 1784766498729885696 |
---|---|
author | Qi Lim, Ping Huey Lim, Sue Sherilyn, Maria Fernandez-Medina, Tulio Ivanovski, Sašo Hosseinpour, Sepanta |
author_facet | Qi Lim, Ping Huey Lim, Sue Sherilyn, Maria Fernandez-Medina, Tulio Ivanovski, Sašo Hosseinpour, Sepanta |
author_sort | Qi Lim, Ping |
collection | PubMed |
description | This study aims to carry out a risk assessment to identify and rectify potential clinical risks of a 3D-printed patient-specific scaffold for large-volume alveolar bone regeneration. A survey was used to assess clinicians’ perceptions regarding the use of scaffolds in the treatment of alveolar defects and conduct a clinical risk assessment of the developed scaffold using the Failure Modes and Effects Analysis (FMEA) framework. The response rate was 69.4% with a total of 41 responses received. Two particular failure modes were identified as a high priority through the clinical risk assessment conducted. The highest mean Risk Priority Number was obtained by “failure of healing due to patient risk factors” (45.7 ± 27.7), followed by “insufficient soft tissue area” (37.8 ± 24.1). Despite the rapid developments, finding a scaffold that is both biodegradable and tailored to the patient’s specific defect in cases of large-volume bone regeneration is still challenging for clinicians. Our results indicate a positive perception of clinicians towards this novel scaffold. The FMEA clinical risk assessment has revealed two failure modes that should be prioritized for risk mitigation (safe clinical translation). These findings are important for the safe transition to in-human trials and subsequent clinical use. |
format | Online Article Text |
id | pubmed-9369557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93695572022-08-12 A Clinical Risk Assessment of a 3D-Printed Patient-Specific Scaffold by Failure Modes and Effects Analysis Qi Lim, Ping Huey Lim, Sue Sherilyn, Maria Fernandez-Medina, Tulio Ivanovski, Sašo Hosseinpour, Sepanta Materials (Basel) Article This study aims to carry out a risk assessment to identify and rectify potential clinical risks of a 3D-printed patient-specific scaffold for large-volume alveolar bone regeneration. A survey was used to assess clinicians’ perceptions regarding the use of scaffolds in the treatment of alveolar defects and conduct a clinical risk assessment of the developed scaffold using the Failure Modes and Effects Analysis (FMEA) framework. The response rate was 69.4% with a total of 41 responses received. Two particular failure modes were identified as a high priority through the clinical risk assessment conducted. The highest mean Risk Priority Number was obtained by “failure of healing due to patient risk factors” (45.7 ± 27.7), followed by “insufficient soft tissue area” (37.8 ± 24.1). Despite the rapid developments, finding a scaffold that is both biodegradable and tailored to the patient’s specific defect in cases of large-volume bone regeneration is still challenging for clinicians. Our results indicate a positive perception of clinicians towards this novel scaffold. The FMEA clinical risk assessment has revealed two failure modes that should be prioritized for risk mitigation (safe clinical translation). These findings are important for the safe transition to in-human trials and subsequent clinical use. MDPI 2022-08-08 /pmc/articles/PMC9369557/ /pubmed/35955377 http://dx.doi.org/10.3390/ma15155442 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Qi Lim, Ping Huey Lim, Sue Sherilyn, Maria Fernandez-Medina, Tulio Ivanovski, Sašo Hosseinpour, Sepanta A Clinical Risk Assessment of a 3D-Printed Patient-Specific Scaffold by Failure Modes and Effects Analysis |
title | A Clinical Risk Assessment of a 3D-Printed Patient-Specific Scaffold by Failure Modes and Effects Analysis |
title_full | A Clinical Risk Assessment of a 3D-Printed Patient-Specific Scaffold by Failure Modes and Effects Analysis |
title_fullStr | A Clinical Risk Assessment of a 3D-Printed Patient-Specific Scaffold by Failure Modes and Effects Analysis |
title_full_unstemmed | A Clinical Risk Assessment of a 3D-Printed Patient-Specific Scaffold by Failure Modes and Effects Analysis |
title_short | A Clinical Risk Assessment of a 3D-Printed Patient-Specific Scaffold by Failure Modes and Effects Analysis |
title_sort | clinical risk assessment of a 3d-printed patient-specific scaffold by failure modes and effects analysis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9369557/ https://www.ncbi.nlm.nih.gov/pubmed/35955377 http://dx.doi.org/10.3390/ma15155442 |
work_keys_str_mv | AT qilimping aclinicalriskassessmentofa3dprintedpatientspecificscaffoldbyfailuremodesandeffectsanalysis AT hueylimsue aclinicalriskassessmentofa3dprintedpatientspecificscaffoldbyfailuremodesandeffectsanalysis AT sherilynmaria aclinicalriskassessmentofa3dprintedpatientspecificscaffoldbyfailuremodesandeffectsanalysis AT fernandezmedinatulio aclinicalriskassessmentofa3dprintedpatientspecificscaffoldbyfailuremodesandeffectsanalysis AT ivanovskisaso aclinicalriskassessmentofa3dprintedpatientspecificscaffoldbyfailuremodesandeffectsanalysis AT hosseinpoursepanta aclinicalriskassessmentofa3dprintedpatientspecificscaffoldbyfailuremodesandeffectsanalysis AT qilimping clinicalriskassessmentofa3dprintedpatientspecificscaffoldbyfailuremodesandeffectsanalysis AT hueylimsue clinicalriskassessmentofa3dprintedpatientspecificscaffoldbyfailuremodesandeffectsanalysis AT sherilynmaria clinicalriskassessmentofa3dprintedpatientspecificscaffoldbyfailuremodesandeffectsanalysis AT fernandezmedinatulio clinicalriskassessmentofa3dprintedpatientspecificscaffoldbyfailuremodesandeffectsanalysis AT ivanovskisaso clinicalriskassessmentofa3dprintedpatientspecificscaffoldbyfailuremodesandeffectsanalysis AT hosseinpoursepanta clinicalriskassessmentofa3dprintedpatientspecificscaffoldbyfailuremodesandeffectsanalysis |